Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets

[scout5]

Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets

Stanford neuroscientist Andrew Huberman has taken aim at mainstream media coverage of peptide therapeutics, calling the broad categorization of these “a dog’s breakfast” that conflates peptides with vastly different regulatory…

calfkicker.com

 

[Gr33dyOctopus]

Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets

Stanford neuroscientist Andrew Huberman has taken aim at mainstream media coverage of peptide therapeutics, calling the broad categorization of these “a dog’s breakfast” that conflates peptides with vastly different regulatory…

calfkicker.com

Ya, he says things are gonna get really really tight on retatrutide, I believe it, stocking up whenever I can.

 

[catdog]

I'm not too worried, there will always be availability of these peptides through loopholes, trust.

 

[Chili777]

"I'll give you my vial when you pry it from my cold, dead hands!" - Me

 

[Flexon]

I'm not too worried, there will always be availability of these peptides through loopholes, trust.

It's true, but all this fear-mongering (and loopholes too) are making the sourcing a real pain in the ass.

 

[Rolltide61]

The CEO of Eli Lilly is David Ricks. His total compensation in 2025 was $36.7 million. The largest shareholders are Vanguard and BlackRock . Eli Lilly is the richest pharma company in the world by market cap. ($930 Billion)

Dave Ricks - Chair/CEO at Eli Lilly and Company | LinkedIn

Chair/CEO at Eli Lilly and Company · A Lilly veteran for more than 25 years, with experience in marketing, sales, drug development and international operations. I became CEO in January 2017 and was elected chair of the company’s board of directors effective June 2017. I serve on the board of...

www.linkedin.com

He wants your vials! You're costing him money!

 

[CNCCurrency]

Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets

Stanford neuroscientist Andrew Huberman has taken aim at mainstream media coverage of peptide therapeutics, calling the broad categorization of these “a dog’s breakfast” that conflates peptides with vastly different regulatory…

calfkicker.com

 

[CNCCurrency]

The CEO of Eli Lilly is David Ricks. His total compensation in 2025 was $36.7 million. The largest shareholders are Vanguard and BlackRock . Eli Lilly is the richest pharma company in the world by market cap. ($930 Billion)

Dave Ricks - Chair/CEO at Eli Lilly and Company | LinkedIn

Chair/CEO at Eli Lilly and Company · A Lilly veteran for more than 25 years, with experience in marketing, sales, drug development and international operations. I became CEO in January 2017 and was elected chair of the company’s board of directors effective June 2017. I serve on the board of...

www.linkedin.com

He wants your vials! You're costing him money!

 

[toologic]

they are also the largest institutional shareholders of Meta and Visa.

 

[Rolltide61]

Sorry I wasted your time.